Cigna Group $CI Shares Sold by Exencial Wealth Advisors LLC

Exencial Wealth Advisors LLC lowered its position in shares of Cigna Group (NYSE:CI) by 1.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,405 shares of the health services provider’s stock after selling 77 shares during the period. Exencial Wealth Advisors LLC’s holdings in Cigna Group were worth $2,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in CI. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group during the 1st quarter worth approximately $28,000. 1248 Management LLC acquired a new stake in shares of Cigna Group during the 1st quarter worth approximately $29,000. Activest Wealth Management increased its holdings in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares during the last quarter. Princeton Global Asset Management LLC increased its holdings in shares of Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after buying an additional 52 shares during the last quarter. Finally, Retirement Wealth Solutions LLC increased its holdings in shares of Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after buying an additional 43 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. The Goldman Sachs Group assumed coverage on shares of Cigna Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $370.00 price objective for the company. Finally, Wells Fargo & Company increased their price objective on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $369.89.

Insider Buying and Selling at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $308.30 on Thursday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 52 week low of $256.89 and a 52 week high of $350.00. The stock has a market capitalization of $82.30 billion, a PE ratio of 16.83, a P/E/G ratio of 0.90 and a beta of 0.45. The firm has a 50 day moving average of $298.83 and a two-hundred day moving average of $307.81.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter last year, the company posted $6.72 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.